{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "16478043",
  "DateCompleted": {
    "Year": "2006",
    "Month": "03",
    "Day": "16"
  },
  "DateRevised": {
    "Year": "2020",
    "Month": "12",
    "Day": "09"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0891-1150",
      "JournalIssue": {
        "Volume": "73",
        "Issue": "2",
        "PubDate": {
          "Year": "2006",
          "Month": "Feb"
        }
      },
      "Title": "Cleveland Clinic journal of medicine",
      "ISOAbbreviation": "Cleve Clin J Med"
    },
    "ArticleTitle": "Clostridium difficile-associated disease: new challenges from an established pathogen.",
    "Pagination": {
      "StartPage": "187",
      "EndPage": "197",
      "MedlinePgn": "187-97"
    },
    "Abstract": {
      "AbstractText": [
        "Clostridium difficile-associated disease (CDAD) can range from uncomplicated diarrhea to sepsis and even death. CDAD rates and severity are increasing, possibly due to a new strain. Transmission of C difficile occurs primarily in health care facilities via the fecal-oral route following transient contamination of the hands of health care workers and patients; contamination of the patient care environment also plays an important role."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Healthcare Quality Promotion, US Centers for Disease Control and Prevention, USA."
          }
        ],
        "LastName": "Sunenshine",
        "ForeName": "Rebecca H",
        "Initials": "RH"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "McDonald",
        "ForeName": "L Clifford",
        "Initials": "LC"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Cleve Clin J Med",
    "NlmUniqueID": "8703441",
    "ISSNLinking": "0891-1150"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Bacterial Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Infective Agents"
    }
  ],
  "CommentsCorrectionsList": [
    {
      "RefSource": "Cleve Clin J Med. 2006 Feb;73(2):105",
      "PMID": "16478035"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Anti-Bacterial Agents"
    },
    {
      "QualifierName": [
        "adverse effects",
        "therapeutic use"
      ],
      "DescriptorName": "Anti-Infective Agents"
    },
    {
      "QualifierName": [
        "isolation & purification",
        "pathogenicity"
      ],
      "DescriptorName": "Clostridioides difficile"
    },
    {
      "QualifierName": [
        "diagnosis",
        "drug therapy",
        "prevention & control"
      ],
      "DescriptorName": "Clostridium Infections"
    },
    {
      "QualifierName": [
        "diagnosis",
        "drug therapy",
        "prevention & control"
      ],
      "DescriptorName": "Cross Infection"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Diagnosis, Differential"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Disease Progression"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Infection Control"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Risk Factors"
    }
  ],
  "NumberOfReferences": "60"
}